Background illustration for clinical trials search

Paid Clinical Trials Glendale

Discover 3,600 paid clinical trials in Glendale, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations

for
Non-small Cell Lung Cancer
Location: Glendale CA, Santa Monica CA, Orange CA, Fresno CA,
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT07195695

Phase 3, Recruiting

An Open-label Study of NNZ-2591 in Pediatric Participants With Phelan-McDermid Syndrome

for
Phelan-McDermid Syndrome
Location: Glendale CA, San Diego CA, San Rafael CA, Houston TX,
Sponsor: Neuren Pharmaceuticals Limited

Sex: All

Age: 3 - 12

Code: NCT07593391

Phase 3, Recruiting

Does Lung Impedance Correlate With Changes in BNP in Stable and Acutely Decompensated Heart Failure Patients?

for
Congestive Heart Failure
Location: Glendale CA, Nashville TN, Charlotte NC, Voorhees NJ,
Sponsor: Southern New Jersey Cardiac Specialists

Sex: All

Age: 18+

Code: NCT00560339

Recruiting
New

A Phase 2a Study Comparing the Efficacy, Safety and Tolerability of Pregabalin Eye Drops Comparing With Timolol Eye Drops in Adults With Glaucoma or High Eye Pressure.

for
Primary Open - Angle Glaucoma (POAG), Ocular Hypertension (OHT)
Location: Glendale CA, Newport Beach CA, Lynchburg VA
Sponsor: Tavo Biotherapeutics

Sex: All

Age: 18+

Code: NCT07913074

Phase 2, Recruiting

A Study of AMDX-2011P in Participants With Primary Open Angle Glaucoma

for
Primary Open Angle Glaucoma
Location: Glendale CA, Newport Beach CA, Phoenix AZ
Sponsor: Amydis Inc.

Sex: All

Age: 22+

Code: NCT06223048

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

OPI-NXYDLD-303 Safety and Efficacy of Phentolamine Ophthalmic Solution in Keratorefractive Surgery Participants With Decreased Mesopic Visual Acuity

for
Vision Loss Night, Vision Disorders
Location: Glendale CA, Pasadena CA, Torrance CA, Newport Beach CA,
Sponsor: Opus Genetics, Inc

Sex: All

Age: 18+

Code: NCT07140783

Phase 3, Recruiting

A Study to Investigate the Relative Bioavailability and Safety of Different Oral Formulations of Elecoglipron in Healthy Participants

for
Healthy Participants
Location: Glendale CA, Brooklyn MD
Sponsor: AstraZeneca

Sex: All

Age: 18 - 55

Code: NCT07723833

Phase 1, Recruiting

Evaluating ER-100 for Safety in People With Glaucoma or Non-Arteritic Anterior Ischemic Optic Neuropathy (Optic Nerve Conditions)

for
Open Angle Glaucoma (OAG),
Location: Glendale CA, Charleston SC, New York NY, Boston MA
Sponsor: Life Biosciences Inc.

Sex: All

Age: 40 - 70+

Code: NCT07290244

Phase 1, Recruiting

A Study to Investigate Safety, Tolerability, and Pharmacokinetics of AZD3974 in Healthy Participants

for
Healthy Participants
Location: Glendale CA, Baltimore MD
Sponsor: AstraZeneca

Sex: All

Age: 18 - 55

Code: NCT07290283

Phase 1, Recruiting

A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of RO7663498 Following Intravitreal Administration in Participants With Diabetic Retinopathy

for
Diabetic Retinopathy
Location: Glendale CA, San Antonio TX, Oak Forest IL, Columbus OH
Sponsor: Hoffmann-La Roche

Sex: All

Age: 18+

Code: NCT07588100

Phase 1, Recruiting

A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated

for
Diabetic Macular Edema
Location: Glendale CA, Beverly Hills CA, Arcadia CA, Oxnard CA,
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT07553429

Phase 1, Phase 2, Recruiting

A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PEAK

for
Macular Edema Secondary to Inflammation
Location: Glendale CA, Los Angeles CA, Pasadena CA, Oxnard CA,
Sponsor: Kodiak Sciences Inc

Sex: All

Age: 18+

Code: NCT06990399

Phase 3, Recruiting

A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PINNACLE

for
Macular Edema Secondary to Inflammation
Location: Glendale CA, Los Angeles CA, Pasadena CA, Oxnard CA,
Sponsor: Kodiak Sciences Inc

Sex: All

Age: 18+

Code: NCT06996080

Phase 3, Recruiting

A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4248 in Healthy Participants and Participants With Chronic Kidney Disease and Type 2 Diabetes and to Assess Home Measurements of Creatinine in a Non Interventional Cohort

for
Chronic Kidney Disease
Location: Glendale CA, San Antonio TX, Saint Paul MN, Chicago IL
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT07024823

Phase 1, Recruiting

A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4954 in Healthy Adult Participants With or Without Elevated Lipoprotein (a) (Lp[a]) Levels, and Participants With Dyslipidemia

for
Healthy Participants, Dyslipidemia
Location: Glendale CA, San Antonio TX, Inverness FL,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70

Code: NCT06980428

Phase 1, Recruiting

Saruparib (AZD5305) Plus Camizestrant or Plus Endocrine Therapy, Compared With CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant in HR-Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified), BRCA1, BRCA2, or PALB2m Advanced Breast Cancer

for
Advanced Breast Cancer
Location: Glendale CA, Los Angeles CA, Fountain Valley CA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06380751

Phase 3, Recruiting

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

for
End Stage Kidney Disease
Location: Glendale CA, Bakersfield CA, Fullerton CA,
Sponsor: CSL Behring

Sex: All

Age: 18+

Code: NCT05485961

Phase 2, Phase 3, Recruiting

A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)

for
Breast Cancer
Location: Glendale CA, Sacramento CA, Albuquerque NM, El Paso TX,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06103864

Phase 3, Recruiting

A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer

for
Metastatic HER2-positive Breast Cancer
Location: Glendale CA, Los Angeles CA, Cerritos CA,
Sponsor: Jazz Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06435429

Phase 3, Recruiting

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

for
Solid Tumor, Non-Small Cell Lung Cancer, Head and Neck Cancer,
Location: Glendale CA, Los Angeles CA, Murrieta CA, Santa Rosa CA,
Sponsor: Inhibrx Biosciences, Inc

Sex: All

Age: 18+

Code: NCT04198766

Phase 1, Phase 2, Recruiting